Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $53.7791 (0.69%) ($53.1844 - $54.1034) on Fri. May. 20, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.43% (three month average) | RSI | 43 | Latest Price | $53.7791(0.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.8% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) VYM(49%) IVE(47%) SPY(47%) IWD(46%) | Factors Impacting ABBV price | ABBV will decline at least -0.715% in a week (0% probabilities). VIXM(-19%) TLT(-14%) UUP(-10%) IGOV(-3%) IPO(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.715% (StdDev 1.43%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
Resistance Level | $55.45 | 5 Day Moving Average | $54.44(-1.21%) | 10 Day Moving Average | $55.48(-3.07%) | 20 Day Moving Average | $55.45(-3.01%) | To recent high | -6.4% | To recent low | 10.4% | Market Cap | $94.882b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |